Physician profile
Robert E Struhl
NPI 1306814975
$4,522.25
in general payments reported to CMS, 2019-2025
34 companies · $1,386 in 2025
The $1,386 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $904 · 2020: $220 · 2021: $226 · 2022: $126 · 2023: $657 · 2024: $1,004 · 2025: $1,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,047.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,046.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $579.36 | 2019-2024 | Jardiance |
| Amgen INC. | $505.62 | 2019-2025 | Otezla, Repatha, Prolia |
| Novartis Pharmaceuticals Corporation | $432.63 | 2019-2025 | |
| Heartflow, INC. | $427.44 | 2024-2025 | |
| Abbott Laboratories | $324.97 | 2019-2024 | Cardiomems |
| Astrazeneca Pharmaceuticals Lp | $182.80 | 2019-2025 | Wainua |
| Medtronic, INC. | $170.98 | 2023 | Cobalt Dr Mri Surescan |
| Takeda Pharmaceuticals U.S.A., INC. | $168.33 | 2025 | Entyvio |
| Inspire Medical Systems, INC. | $157.31 | 2025 | Inspire |
| Novo Nordisk INC | $157.09 | 2019-2025 | Ozempic, Wegovy |
| Boston Scientific Corporation | $146.56 | 2024 | Watchman Flx |
| Bayer Healthcare Pharmaceuticals INC. | $136.04 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $129.83 | 2019-2023 | Camzyos |
| Glaxosmithkline, LLC. | $123.82 | 2024 | Arexvy |
| Alnylam Pharmaceuticals INC. | $122.83 | 2023 | Amvuttra |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $96.22 | 2021-2025 | Capvaxive, Gardasil 9, Gardasil |
| Exact Sciences Corporation | $91.15 | 2025 | Cologuard Collection Kit |
| Edwards Lifesciences Corporation | $71.11 | 2019-2021 | |
| Pfizer INC. | $65.15 | 2019-2025 | |
| Medicomp INC | $64.04 | 2024-2025 | Telepatch Cardiac Monitor |
| Sanofi-Aventis U.S. LLC | $60.05 | 2019 | |
| Abbvie INC. | $47.15 | 2019 | |
| Amneal Pharmaceuticals LLC | $45.12 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $25.62 | 2021 | |
| Eisai INC. | $22.83 | 2019 | |
| Celltrion USA INC. | $22.71 | 2025 | Vegzelma |
| Vifor Pharma, INC. | $21.89 | 2019 | |
| Amarin Pharma, INC. | $21.36 | 2019 | |
| Bridgebio Pharma, INC. | $20.13 | 2025 | Attruby |
| Mannkind Corporation | $18.45 | 2025 | |
| Vivaquant INC, Dba Rhythm Express | $17.40 | 2025 | Rhythm Express |
| Esperion Therapeutics, INC. | $16.98 | 2024 | Nexletol |
| Janssen Pharmaceuticals, INC | $16.95 | 2019 | |
| Corcept Therapeutics | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Struhl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.